Skip to main content

Home/ Healthcare 2.0/ Group items matching "Treating" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
1More

What is Ear Candling Treatment, How Worth its Using? - 0 views

  •  
    Ear candles have been used for various purposes, from removing wax to curing ear infections and improving hearing. Not only that, but it is also an excellent way for treating issues related to ears like a sinus infection, swimmer's ear, headache, sore throat, flu, and cold.
1More

The Role of Precision Medicine in Smart Healthcare - 0 views

  •  
    For patients, precision medical technology is changing their lives with enhanced patient care, increased access to healthcare, and improved results. On the service side, a number of new technological innovations can now be incorporated into service delivery: automation, artificial intelligence (A.I), robots, precision medicine, genomics, and more. On the information side, information systems are incorporating data from various areas of health care into a single platform, allowing for accurate diagnosis and treatment, improved medication compliance, and a wider variety of personalized care. This is the ultimate goal of precision medicine, which helps hospitals and physicians to provide patients with the best possible healthcare. In some ways, smart hospitals have been the primary driver of precision medicine. While the field of medicine may be relatively new, Smart healthcare providers have already made significant strides in their ability to provide patients with personalized care based on medical history and the patient's specific symptoms, physical conditions, and preferences. These advances have improved patients' overall quality of life, while enabling smart healthcare providers to deliver the most appropriate care and therapies possible. One of the most critical facets of precision medicine is the introduction of electronic health records (EHRs). Through EHRs, health care providers can gather, manage, and integrate all of the patient's important information into one centralized database. As EHRs become more popular, smart healthcare providers can leverage existing patient data to reduce the complexity of EHR systems and improve overall quality of care. Moreover, EHRs can also streamline medical procedures, ensuring that patients receive the same level of care whether they are being treated at a hospital or at a home. Read More @ https://www.blogger.com/blog/post/edit/preview/9197580861156902959/4942274716305382665
1More

Increasing Prevalence of Chronic Diseases to Augment Growth of the Biologics Market - 0 views

  •  
    A biologic drug (biologics) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Biologics drugs are derived from a wide variety of natural sources such as human, animal, or microorganisms by using biotechnology. Moreover, Biologics include a wide variety of products such as blood and blood components, vaccines, tissues, allergenic, gene therapy, somatic cells, and recombinant therapeutic proteins. Novel therapies and new technologies are emerging to create new biologics, which holds a prominent future for the biologics market. The market is majorly driven by the increasing prevalence of chronic diseases across the globe, growing capital investment by key players, and higher acceptability and increasing demand for innovative therapies. For instance, according to the National Health Council, around 157 million Americans are expected to have more than one chronic disorder by 2020. Moreover, according to the World Health Organization, diabetes, cancer, and cardiovascular diseases account for around 1.6 million, 9 million, and 17.9 million deaths each year, respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/11/increasing-prevalence-of-chronic.html
1More

Rapid Growth on Kidney Stone Management Devices Market 2021 by New Market Opportunities... - 0 views

  •  
    Kidney stones, also known as renal calculi, occur when the liquid stored in the kidneys becomes too concentrated. The stone, once lodged in the urinary tract, obstructs the urine flow from it and causes great pain in the abdomen. Other symptoms of a kidney stone include a burning sensation or an intense desire to urinate frequently. Also experiencing frequent urge to pass urine. Kidney stones can be treated effectively, due to presence of advanced methods and associated medical devices. Kidney stone management devices are widely used to retrieve kidney stones. Increasing prevalence of kidney stones and the increasing preference for minimally invasive surgeries worldwide is expected to propel the growth of the kidney stone management devices market. For instance, according to the United States National Kidney Foundation, every year, more than half a million people go to emergency rooms for kidney stone problems. It is estimated that one in ten people will have a kidney stone at some time in their lives. Moreover, increasing product launches, technological advancements, and increasing research and development activities for the prevention and treatment of kidney stones is expected to augment the growth of the kidney stone management devices market. For instance, in August 2020, Dornier MedTech (Dornier) announced the launch of UroX, a community that connects professionals from various disciplines to cultivate innovation and solve the most pressing challenges in urology. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-prevalence-of-kidney-stones.html
1More

Myelofibrosis Treatment Market Continues To Grow Owing To the Demand from Healthcare Se... - 0 views

  •  
    Myelofibrosis Treatment includes medications and surgery. There are drugs and medicines which are used to cure myelofibrosis. Myelofibrosis is a muscle disease and various types of myelofibrosis treatment are available in the market to cure this condition. The muscle disease is caused due to myelodysplasia, a genetically determined trait that prevents the muscle from growing properly. Myelofibrosis is also known as spider veins, lying in regions close to the skin, like the armpits, groin, elbows, and knees. Myelofibrosis is the most common type of connective tissue disease. These medicines are generally used to control and stop the progress of the disease, after which, they suppress the activity of the immune system. Various types of steroids are used as medicines for myelofibrosis, to control the activity of the immune system and thereby stop the disease in its tracks. One of the most common drugs for myelofibrosis treatment is prednisone, which is generally used along with steroids. However, to treat spider veins and not myelofibrosis, a compound called Finasteride is used. The most important part of myelofibrosis treatment is a regular check-up, as early as 18 months of the disease a doctor can monitor the progress of the disease. Myelofibrosis treatment also includes physical therapy and other treatments to improve the symptoms of myelofibrosis. The main driving factor influencing the growth of the myelofibrosis treatment market is the increasing prevalence of myelofibrosis in emerging economies. For instance, according to Gleneagles Global Hospitals, the yearly incidence rate of myelofibrosis in India is 0.3 to 1.5 cases per 100,000 individuals. Most of the times these cases goes unnoticed since it is sometimes asymptomatic or less severe. Moreover, the market is estimated to grow owing to a large number of R&D investments, a large cluster of patients suffering from myelofibrosis, and better reimbursement policies. Read more @ https://coherentmarketinsights-bl
1More

Rise in Number of Cardiovascular Surgery around the Globe is Impelling the Growth of th... - 0 views

  •  
    Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html
1More

Rapid Growth on Pulmonary Arterial Hypertension (PAH) Market Segmented by Application, ... - 0 views

  •  
    Pulmonary Arterial Hypertension (PAH) is a disease that affects the vasculature of the heart, specifically the arteries that transport blood from the heart to the lungs. Common symptoms include heart palpitations or an irregular rhythm, chest pain, coughing, wheezing, shortness of breath, chest discomfort when breathing, and sometimes even heart failure. The cause of pulmonary hypertension is not known, but research has indicated that genetic and hormonal factors may play a role in its development. The growing prevalence of Pulmonary Arterial Hypertension (PAH) is driving the growth of the Pulmonary Arterial Hypertension (PAH) Market. According to the European Respiratory Society, PAH is a rare disease, with an estimated prevalence ranging from 10 to 52 cases per million. The growing geriatric population is again increasing the prevalence of such disease which is also projected to foster the growth of the Pulmonary Arterial Hypertension (PAH) market. According to the United nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. North America is projected to gain significant growth over the forecast period and this is attributed to the growing adoption of advanced treatment for treating pulmonary arterial hypertension. Moreover, increasing spending by the government on the healthcare sector is again augmenting the regional market growth. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028. Reads more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-global-healthcare-spending.html
1More

Medical Ceramics Market is Expanding Rapidly with Zimmer Biomet Holdings, Inc. Complete... - 0 views

  •  
    Medical ceramics are ceramics that have the properties to be used as the direct medium of medical procedures. They are made from a number of different materials including porcelain, enamel, ceramic, polymers, and other materials. The ceramic material is used to serve the purpose of impregnating the substances on the affected part so that they get affected by the required heat and are changed into a non-toxic and safe substance. Increasing demand for implantable devices is expected to drive the growth of the global medical ceramics market. The demand for implantable devices offer additional advantages including the ability to selectively activate grouping of fibers within the nerve. Major companies operating in the market are focused on research and development activities, in order to gain a significant edge in the competition. For instance, in December 2020, W. L. Gore and Associates, Inc. received the U.S. Food and Drug Administration (FDA) approval for its Gore Excluder Comfortable (EXCC) AAA Endoprosthesis to treat patients with aneurysm of the infrarenal abdominal aorta. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/medical-ceramics-market-is-expanding.html
1More

Gastritis in Mumbai - Apollo Hospitals Mumbai - 0 views

  •  
    Apollo Hospitals Mumbai offers gastritis treatment which is medical gastroenterology in which the aim is to diagnose, prevent and treat disorders in both children and adults.
1More

Spinal Tumor in Mumbai - Apollo Hospitals Mumbai - 0 views

  •  
    Apollo Hospitals Mumbai offers a spinal tumor treatment in which most inaccessible areas are treated by high-powered microscopes in the surgery.
1More

Non-Alcoholic Fatty Liver Disease (NAFLD) in Mumbai - Apollo Hospitals Mumbai - 0 views

  •  
    Apollo hospitals Mumbai offers Non-Alcoholic Fatty Liver disease treatment, this disease if not treated can result in significant liver damage for those affected.
1More

Dr. Ravi Mohanka Offering Exceptional Outcomes for Liver Transplant Patients - 0 views

  •  
    Dr. Ravi Mohanka at Global hospital for liver transplant, brings together a multidisciplinary team of highly professional health workers who're experienced in treating patients with end-stage liver disease
1More

Cancer Doctors in India Committed to Delivering the Highest Quality of Prostate Cancer ... - 0 views

  •  
    The best hospitals for Prostate Cancer Treatment in India can go to any extent to treat a cancer patient, even if it makes them import a new technology from abroad
1More

Multiple Myeloma Drugs are Getting Better with Major Pharmaceutical Companies Laying Em... - 0 views

  •  
    Multiple myeloma is a type of cancer that forms a type of white blood cell called a plasma cell. In multiple myeloma, cancerous plasma cells gather around the bone marrow and crowd out healthy cells. Some of the most common symptoms of multiple myeloma are pain in the back or bones, anemia, fatigue, and kidney damage. Multiple myelomas can be identified by a biopsy, which is conducted when tissue samples from the affected area are taken and examined under a microscope. When multiple myelomas are detected on an examination, it is typically very easy to remove them with a scalpel, and in many cases, surgeons will opt to remove only one lobe of tissue at a time. There has the development of various multiple myeloma drugs over the years with key industry players being involved in continuous research and development activities. Selinexor is one of the latest U.S. FDA-approved drug for multiple myeloma and is used to treat people suffering from relapsed or refractory disease. Furthermore, Ixazomib is the first and only oral proteasome inhibitor, indicated for multiple myeloma treatment. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/multiple-myeloma-drugs-are-getting.html
1More

Coherent Market Insights_CMI_Blog: The rise in prevalence of Peptic Ulcer and progressi... - 0 views

  •  
    Peptic ulcer drugs are medicines that are used to help fight and treat the symptoms of ulcers in stomach. These drugs, when taken regularly, can stop the production of certain hormones, such as pancreatic enzymes which are responsible for the digestion of foods. When the stomach produces too many enzymes, this can result in a painful ulcer. The first introduction of Peptic Ulcer Drugs was in the 1930s and it is still an important part of medical treatment today. Histological research on ulcers in patients who had undergone ulcer surgery showed that ulcers developed because of a reduced digestive system and inadequate absorption of nutrients in the intestines. The first Peptic Ulcer Drugs, introduced in the United States were drugs which helped to improve the absorption and metabolism of proteins and carbohydrates in the bloodstream. Other Peptic Ulcer Drugs include drugs that reduce the inflammation of the lining of the stomach and lower the levels of certain enzymes which can cause ulcer growth. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/the-rise-in-prevalence-of-peptic-ulcer.html
1More

Get Back to Life After Prostate Cancer Surgery in India - 0 views

  •  
    The multi-specialty hospitals in India are best regarded in treating prostate cancer surgery in India which can be equipped with a competent team of exceptional pancreatic cancers surgeons and hospitals
1More

Hereditary Angioedema Market to Witness Robust Growth as BioCryst Pharmaceuticals, Inc.... - 0 views

  •  
    Hereditary Angioedema is a disease, which is the result of genetic mutation, within the families with higher genetic activity. It is not contagious to others. The cause of heredity is still unknown but it is believed that the disease is related to the immunological mechanism. Hereditary Angioedema is a chronic non-inflammatory disease that affects millions of people around the world. Symptoms include persistent dryness of the skin, scalp itching, inflammation, rash, severe skin peeling and cracking, bleeding and hives, pain in the area where the skin is affected. As a part of the diagnosis, a medical practitioner who is experienced in treating hereditary angioedema must do a skin biopsy to find out the exact cause of allergic skin reaction. Rising awareness regarding hereditary angioedema is expected to drive growth of the global hereditary angioedema market during the forecast period. Hereditary angioedema or also referred to as HAE has received significant attention in the recent past as government and non-government organizations across the globe are focused on increasing public awareness to improve diagnosis and enhance the treatment. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/hereditary-angioedema-market-to-witness.html
1More

Starpharma Holdings Limited Received a Patent for SPL7013 Ophthalmic Drops for Viral Co... - 0 views

  •  
    The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html
1More

Human Growth Hormone (hGH) Market Analysis of Factors that Drive and Restrain... - 0 views

  •  
    In humans, a deficiency of growth hormone is caused when the pituitary gland does not include adequate concentration of human growth hormone. This deficiency is treated by injecting human growth hormone with a subcutaneous injection. Various genetic disorders such as Prader-Willi syndrome and Turner syndrome can also cause growth hormone deficiency, resulting in delayed puberty and shorter height than averages.
1More

Molnova Molnupiravir Capsules - Best Medicine for Corona - 0 views

  •  
    Our offered Molnova molnupiravir capsules are proved as best medicine for corona. We have made available it for everyone. Molnupiravir capsules are available with the brand name of Molnova. It is known as best anti viral medicine to treat latest corona viruses.
« First ‹ Previous 61 - 80 of 112 Next › Last »
Showing 20 items per page